BIOFRONTERA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.342 EUR | -2.84% |
|
-2.29% | -14.71% |
| Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOFRONTERA AG | Other Pharmaceuticals | -2.84% | -2.29% | -14.71% | -70.26% | -94.87% | 23.5M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- B8F Stock
- Charts Biofrontera AG
- Comparison Chart